Date updated:05-08-2007
Bird Flu

-
ENDP
Endo Pharmaceutic - $20.25
- -15.80%
- $21.75
Symmetrel, FDA-approved to treat influenza A*

-
CARN
Carn - $0.00
- N/A
- $N/A
Rec'd $6M grant from U.S. to develop H5N1 vaccine

-
DVAX
Dynavax Technolog - $0.87
- +0.02%
- $0.899
Imunostimulatory sequence technology to target virus

-
VICL
Vical Incorporate - $1.41
- +4.44%
- $1.34
Developing DNA-based vaccine vs. H5N1

-
AVAN
Avan - $0.00
- N/A
- $N/A
Announced plans to research H5N1 vaccine

-
AVII
Avi Biopharma - $0.85
- +18.06%
- $0.75
Antisense-based therapeutic

-
CRXL
Crucell Nv - $16.07
- +2.68%
- $15.66
PER.C6 tech used by Sanofi in H5N1 vaccine development

-
HEB
Hemispherx Biopha - $0.44
- +0.02%
- $0.47
Alferon, stimulates Interferon to defend vs. H5N1
- Bird Flu's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Templeton World A (TEMWX)
- 5. Fidelity Select Consum...
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
At Stockpickr.com, we strive to keep track of insider purchasing and buybacks each week. Here's the perfect setup in my mind: insiders buying the stock, the company buying ...
The traders of CNBC’s "Fast Money" think the current stock market is a traders' market. In order to play a traders' market, you have to nimble. You also have to know whic...
Pfizer (PFE) CEO Jeff Kindler has hinted that the world’s biggest drugmaker is open to a large-scale acquisition. “The real goal is to grow revenues," he told the Fina...
A. small trading before thrusday
Analyst Downgrades for Jan. 5, 2009 more
These stocks were upgraded by TheStreet.com Ratings on Dec. 29, 2008. more
These stocks were downgraded by TheStreet.com Ratings on Dec. 29, 2008. more








Comments not available